Health
Scientists identify a new drug target for dry age-related macular degeneration – Medical Xpress
Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that the blood protein vitronectin is a promising drug target for dry age-related macular degeneration (AMD), a leading cause of vision loss in Americans 60 years of age and older. Th…
Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that the blood protein vitronectin is a promising drug target for dry age-related macular degeneration (AMD), a leading cause of vision loss in Americans 60 years of age and older. The study, published in the Proceedings of the National Academy of Sciences (PNAS), also holds implications for Alzheimer’s and heart disease, which are linked to vitronectin.
“Our findings suggest that vitronectin, which is shaped like a sti…
-
Business16 hours ago3 US dividend stocks that can boost an ASX retirement portfolio
-
Business13 hours agoTop brokers name 3 ASX shares to buy next week 16 November 2025
-
General23 hours agoEngland completes sole Ashes warm-up match with flurry of runs to Ollie Pope, Joe Root
-
General20 hours agoDemocratic Republic of Congo and M23 rebel group sign new roadmap to peace in Qatar